Ceftaroline fosamil doses and breakpoints forStaphylococcus aureusin complicated skin and soft tissue infections

Shampa Das; Jianguo Li; Joseph Iaconis; Diansong Zhou; Gregory G Stone; Jean Li Yan; David Melnick

doi:10.1093/jac/dky439

Ceftaroline fosamil doses and breakpoints forStaphylococcus aureusin complicated skin and soft tissue infections

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dky439 ◽

2018 ◽

Vol 74 (2) ◽

pp. 425-431 ◽

Cited By ~ 11

Author(s):

Shampa Das ◽

Jianguo Li ◽

Joseph Iaconis ◽

Diansong Zhou ◽

Gregory G Stone ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Infections ◽

Ceftaroline Fosamil ◽

Complicated Skin

Download Full-text

Ceftaroline Fosamil: A Review of its Use in the Treatment of Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia

Drugs ◽

10.1007/s40265-013-0075-6 ◽

2013 ◽

Vol 73 (10) ◽

pp. 1067-1094 ◽

Cited By ~ 39

Author(s):

James E. Frampton

Keyword(s):

Soft Tissue ◽

Community Acquired Pneumonia ◽

Soft Tissue Infections ◽

Ceftaroline Fosamil ◽

Complicated Skin

Download Full-text

Ceftaroline Fosamil: A Review in Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia

Drugs ◽

10.1007/s40265-016-0654-4 ◽

2016 ◽

Vol 76 (17) ◽

pp. 1659-1674 ◽

Cited By ~ 8

Author(s):

Lesley J. Scott

Keyword(s):

Soft Tissue ◽

Community Acquired Pneumonia ◽

Soft Tissue Infections ◽

Ceftaroline Fosamil ◽

Complicated Skin

Download Full-text

Impact of Underlying Comorbidities on Outcomes of Patients Treated with Ceftaroline Fosamil for Complicated Skin and Soft Tissue Infections: Pooled Results from Three Phase III Randomized Clinical Trials

Infectious Diseases and Therapy ◽

10.1007/s40121-021-00557-w ◽

2021 ◽

Author(s):

Mark Wilcox ◽

Jean Li Yan ◽

Pedro L. Gonzalez ◽

Matthew Dryden ◽

Gregory G. Stone ◽

...

Keyword(s):

Clinical Trials ◽

Soft Tissue ◽

Randomized Clinical Trials ◽

Phase Iii ◽

Soft Tissue Infections ◽

Ceftaroline Fosamil ◽

Three Phase ◽

Complicated Skin

Download Full-text

Zinforo (Ceftaroline Fosamil) Versus other Empiric Initial IV Antibiotics for Complicated Skin and Soft Tissue Infections (CSSTI): A Network Meta-Analysis

Value in Health ◽

10.1016/j.jval.2016.09.355 ◽

2016 ◽

Vol 19 (7) ◽

pp. A408

Author(s):

N Rao ◽

E Gibson ◽

RW Lawson ◽

JJ Goodall

Keyword(s):

Soft Tissue ◽

Meta Analysis ◽

Soft Tissue Infections ◽

Ceftaroline Fosamil ◽

Complicated Skin

Download Full-text

Correction to: Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia

Pediatric Drugs ◽

10.1007/s40272-021-00474-y ◽

2021 ◽

Author(s):

Susanna Esposito ◽

Timothy J. Carrothers ◽

Todd Riccobene ◽

Gregory G. Stone ◽

Michal Kantecki

Keyword(s):

Soft Tissue ◽

Community Acquired Pneumonia ◽

Soft Tissue Infections ◽

Ceftaroline Fosamil ◽

Complicated Skin

Download Full-text

Baseline Characteristics and Outcomes Among Patients with Complicated Skin and Soft Tissue Infections Admitted to the Intensive Care Unit: Analysis of the Phase 3 COVERS Randomized Trial of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam

Infectious Diseases and Therapy ◽

10.1007/s40121-020-00297-3 ◽

2020 ◽

Vol 9 (3) ◽

pp. 609-623

Author(s):

Miguel Sánchez-García ◽

Jennifer Hammond ◽

Jean Li Yan ◽

Michal Kantecki ◽

Wajeeha Ansari ◽

...

Keyword(s):

Intensive Care Unit ◽

Intensive Care ◽

Soft Tissue ◽

Randomized Trial ◽

Soft Tissue Infections ◽

Phase 3 ◽

Ceftaroline Fosamil ◽

Complicated Skin ◽

Baseline Characteristics ◽

Unit Analysis

Download Full-text

PIN3 COSTS AND CONSEQUENCES OF CEFTAROLINE FOSAMIL FOR THE TREATMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS (CSSTI) IN BRAZILIAN PRIVATE HEALTHCARE SYSTEM

Value in Health Regional Issues ◽

10.1016/j.vhri.2019.08.234 ◽

2019 ◽

Vol 19 ◽

pp. S40

Author(s):

R.F. Alexandre ◽

C. Salgado De Santana ◽

T. Senna

Keyword(s):

Soft Tissue ◽

Healthcare System ◽

Soft Tissue Infections ◽

Ceftaroline Fosamil ◽

Private Healthcare ◽

Complicated Skin

Download Full-text

The Use of Extrapolation Based on Modeling and Simulation to Support High‐Dose Regimens of Ceftaroline Fosamil in Pediatric Patients with Complicated Skin and Soft‐Tissue Infections

CPT Pharmacometrics & Systems Pharmacology ◽

10.1002/psp4.12608 ◽

2021 ◽

Author(s):

Phylinda L.S. Chan ◽

Lynn McFadyen ◽

Andrea Quaye ◽

Heidi Leister‐Tebbe ◽

Victoria M. Hendrick ◽

...

Keyword(s):

Soft Tissue ◽

Modeling And Simulation ◽

Pediatric Patients ◽

High Dose ◽

Soft Tissue Infections ◽

Ceftaroline Fosamil ◽

Complicated Skin

Download Full-text

PIN7 Efficacy of Ceftaroline Fosamil and Other Intravenous Antibiotics in the Treatment of Complicated Skin and Soft Tissue Infections (CSSTI): A Network Meta-Analysis (NMA)

Value in Health ◽

10.1016/j.jval.2012.08.1074 ◽

2012 ◽

Vol 15 (7) ◽

pp. A385-A386 ◽

Cited By ~ 1

Author(s):

G. Medic ◽

A. Karabis ◽

J. Borrill ◽

J. Worrall ◽

G. Bergman

Keyword(s):

Soft Tissue ◽

Meta Analysis ◽

Soft Tissue Infections ◽

Ceftaroline Fosamil ◽

Intravenous Antibiotics ◽

Complicated Skin

Download Full-text

Ceftaroline fosamil treatment outcomes compared with standard of care among hospitalized patients with complicated skin and soft tissue infections

Journal of Comparative Effectiveness Research ◽

10.2217/cer-2015-0024 ◽

2016 ◽

Vol 5 (4) ◽

pp. 393-405 ◽

Cited By ~ 3

Author(s):

Sudeep Karve ◽

Judith Hackett ◽

Jeremy Levinson ◽

Edward Gibson ◽

Alysia Battersby

Keyword(s):

Soft Tissue ◽

Treatment Outcomes ◽

Standard Of Care ◽

Hospitalized Patients ◽

Soft Tissue Infections ◽

Ceftaroline Fosamil ◽

Complicated Skin

Download Full-text